Netherlands· NL-a8f284aee43a

Acitretine CF 25 mg, capsules

A acitretin product containing acitretine, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC D05BB02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about acitretineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Acitretin is registered in 17 of 19 countries.

Countries holding a registration under ATC D05BB02 (acitretin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search acitretin products by name

Acitretin · ATC D05BB02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acitretin costs, country by country.

Normalised to the WHO defined daily dose (35 mg), the median price runs from $2.08 in Italy to $4.37 in Switzerland — a ×2.1 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Acitretin · price per daily dose (35 mg)

USD · FX 28 Sept 2026

CH Switzerland$4.37
IT Italy$2.08

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ACITRETINE
Manufacturer: Centrafarm B.V.
Country: Netherlands (NL)
ATC code: D05BB02
ATC class: Acitretin
Defined daily dose: 35 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
107066

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

147 interactions on record for acitretin.

Graded by severity as the source publishes them — 39 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check acitretin against other medicines How interaction checks work

Acitretin · interactions on record

147 records

39 severe
30 moderate
75 info

Most severe, free to view

EthanolB05XX04severe
MipomersenC10AX11severe
LomitapideC10AX12severe
IsotretinoinD10AD04severe

3 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Acitretin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acitretin products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Keracutan
Belgium · Neotigason
Czechia · Neotigason
Germany · Acicutan, Neotigason
Denmark · Acitretin Orifarm, Neotigason
Estonia · Neotigason
Spain · Acitretina Ifc, Neotigason
Finland · Acitretin Orifarm, Neotigason
France · Soriatane
United Kingdom (Northern Ireland) · Acitretin Genus Pharmaceuticals, Acitretin Morningside Healthcare
Croatia · Neotigason
Hungary · Neotigason
Ireland · Neotigason
Iceland · Neotigason
Italy · Neotigason, Zorias
Lithuania · Neotigason
Luxembourg · Neotigason
Latvia · Neotigason
Norway · Acitretin Orifarm, Neotigason
Poland · Acitren, Neotigason
Portugal · Neotigason
Sweden · Acitretin Orifarm, Neotigason
Slovenia · Neotigason
Slovakia · Neotigason

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/7d37d3de-cb2e-407f-8c3a-071508c33c21
GET /v1/drugs/7d37d3de-cb2e-407f-8c3a-071508c33c21?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h107066_smpc.pdf",
  "strength": null,
  "atc_label": "Acitretin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg107066",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GELATINE (E 441)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MALTODEXTRINE",
    "NATRIUMASCORBAAT (E 301)",
    "NATRIUMLAURILSULFAAT",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "ACITRETINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h107066.pdf",
  "authorised_at": "2011/03/17",
  "procedure_number": "NL/H/1959/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "107066",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about acitretin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console